Vitamin D and K2 are paired together because they work as a team to manage calcium in your body. Vitamin D increases how much calcium you absorb from food, but it doesn’t control where that calcium ends up. Vitamin K2 activates the proteins that direct calcium into your bones and teeth while keeping it out of your arteries and soft tissues. Without enough K2, the extra calcium that vitamin D helps you absorb can deposit in the wrong places.
How the Two Vitamins Handle Calcium
Vitamin D’s primary job in calcium metabolism is straightforward: it increases calcium absorption in your intestines. When your vitamin D levels are adequate, your gut pulls more calcium from the food you eat into your bloodstream. This is why vitamin D is so closely linked to bone health. But absorbing calcium is only half the equation. Your body also needs a way to route that calcium to the right destinations.
That’s where K2 comes in. Vitamin D actually triggers your body to produce more of certain proteins that depend on vitamin K2 to function. Two of the most important are osteocalcin and matrix Gla protein (MGP). These proteins are produced in inactive forms. Vitamin K2 “switches them on” through a chemical process called carboxylation. Once activated, osteocalcin drives calcium into bone tissue and stimulates mineralization, while MGP acts as one of the body’s strongest natural inhibitors of calcification in blood vessels. MGP works by binding to calcium and phosphate in the bloodstream and preventing them from forming hard crystal deposits on artery walls.
So vitamin D boosts calcium absorption and increases the production of these routing proteins, but K2 is the nutrient that makes those proteins functional. If you take vitamin D without adequate K2, you’re increasing calcium intake while leaving the traffic signals turned off.
The Risk of Calcium in Your Arteries
When calcium accumulates in artery walls, it stiffens them and contributes to cardiovascular disease. Activated MGP prevents this by binding to calcium crystals before they can build up in vascular tissue. It essentially acts as a shuttle, grabbing free calcium from the circulation and helping transport it toward bone instead. MGP also protects the smooth muscle cells lining your arteries from transforming into bone-like cells, a process that accelerates calcification.
The evidence supporting this mechanism is consistent across several lines of research. People who take vitamin K antagonists (blood-thinning medications that block vitamin K activity) for long periods show increased vascular calcification in observational studies. In animal models, mice with inactivated MGP developed rapid and severe arterial calcification. And in a recent two-year trial testing high-dose K2 (720 mcg per day) combined with vitamin D in patients with coronary artery calcification, the combination appeared to slow calcification progression, particularly in patients who already had severe buildup. The combination of vitamins D and K also showed less thickening of the carotid artery wall compared to vitamin D taken alone.
K2 May Protect Against Vitamin D Toxicity
High-dose vitamin D supplementation raises the risk of hypercalcemia, a condition where calcium levels in the blood become dangerously elevated. But a compelling hypothesis published in the journal Medical Hypotheses proposes that much of vitamin D’s toxicity actually stems from inducing a vitamin K deficiency. The reasoning: vitamin D ramps up production of K-dependent proteins, which burns through your K2 stores faster. When K2 runs out, calcium can’t be properly directed, leading to soft tissue calcification, bone loss, and other toxic effects that researchers have shown can occur independently of high blood calcium levels.
This framing suggests that taking K2 alongside vitamin D doesn’t just optimize the benefits. It may also widen the safety margin for vitamin D supplementation by ensuring the proteins vitamin D produces can actually do their jobs.
MK-4 vs. MK-7: Which Form of K2 Matters
Vitamin K2 comes in several forms, but the two you’ll encounter in supplements are MK-4 and MK-7. They differ significantly in how well your body can use them.
MK-7, found naturally in fermented foods like natto, has far superior bioavailability. In a direct comparison study, participants who took 60 mcg of MK-7 reached peak blood levels at 6 hours, and the vitamin remained detectable for up to 48 hours. MK-4 at the same dose? It was undetectable in every participant at every time point. Even after seven consecutive days of supplementation, MK-4 failed to raise blood levels, while MK-7 increased them significantly in all subjects.
Perhaps the most surprising finding: in animal studies, MK-7 supplementation actually raised MK-4 levels in tissues throughout the body, while supplementing with MK-4 itself did not. This means MK-7 is a better supplier of MK-4 to your bones and blood vessels than MK-4 is on its own. MK-7’s longer half-life also provides more sustained activation of osteocalcin, making it the preferred form in most combined D3/K2 supplements.
Food Sources of K2
The richest dietary source of K2, by a wide margin, is natto. A 3-ounce serving provides roughly 850 mcg of MK-7, which is over 700% of the daily value for vitamin K. No other common food comes close. Cheese, chicken, and ground beef contain modest amounts of the MK-4 form, typically between 2 and 13 mcg per serving. Cheddar cheese provides about 4 mcg per 1.5 ounces, and rotisserie chicken breast provides about 13 mcg per 3 ounces.
Unless you eat natto regularly, it’s difficult to get meaningful amounts of K2 from diet alone, which is one practical reason K2 supplements exist and why they’re commonly bundled with vitamin D.
Dosing Considerations
There is no universally established ratio of vitamin D3 to K2. Clinical trials have used K2 doses ranging from 180 mcg to 720 mcg per day, with research showing a dose-dependent decrease in inactive (uncarboxylated) MGP at both 180 and 360 mcg daily. Many combined supplements pair 5,000 IU of D3 with 90 to 200 mcg of MK-7, a range that reflects common clinical practice rather than formal guidelines.
One important caution: if you take warfarin or another vitamin K antagonist, even small changes in vitamin K intake can shift your blood clotting levels. Studies have found that roughly 12% of warfarin-treated patients in some clinics have undetectable vitamin K levels, making them especially sensitive to any change in intake. Starting or stopping a K2 supplement without informing your prescriber can destabilize anticoagulation control. The standard advice for anyone on these medications is to keep vitamin K intake consistent day to day and to communicate any planned changes.